Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 6/20 | 0.60 |
| ▸ | PMM2 | O15305 | 7/20 | 0.58 |
| ▸ | MPI | P34949 | 7/20 | 0.58 |
| ▸ | PHOSPHO1 | Q8TCT1 | 6/20 | 0.58 |
| ▸ | APOBEC3G | Q9HC16 | 5/20 | 0.58 |
| ▸ | PKM | P14618 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.58 |
| ▸ | CASP3 | P42574 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | IDE | P14735 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17502097 | 0.87 | G6PD (0.54) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL1895902 | 0.82 | MPI (0.60) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL18845247 | 0.79 | G6PD (0.66) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL26645117 | 0.76 | MPI (0.64) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL8624454 | 0.76 | G6PD (0.66) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL8373401 | 0.76 | G6PD (0.72) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL8372604 | 0.76 | MPI (0.72) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL18913002 | 0.75 | MPI (0.73) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL1898397 | 0.74 | MPI (1.00) | G6PDPMM2MPIPHOSPHO1APOBEC3G | |
| SCHEMBL30562926 | 0.74 | MPI (1.00) | G6PDPMM2MPIPHOSPHO1APOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11801262-B2 | Antibiotic compositions | THIOREDOXIN SYSTEMS AB (SE) | 2023-10-31 | — | — | US | disclosed |
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | THIOREDOXIN SYSTEMS AB (SE) | 2021-05-25 | — | — | US | disclosed |
| US-20200281967-A1 | Antibiotic Compositions | THIOREDOXIN SYSTEMS AB (SE) | 2020-09-10 | — | — | US | disclosed |
| US-10653717-B2 | Antibiotic compositions | THIOREDOXIN SYSTEMS AB (SE) | 2020-05-19 | — | — | US | disclosed |
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | MOLECULAR DEFENSES CORP (US) | 2019-10-10 | — | — | US | disclosed |
| US-20180185410-A1 | Antibiotic Compositions | THIOREDOXIN SYSTEMS AB (SE) | 2018-07-05 | — | — | US | disclosed |
| WO-2017091737-A1 | PHARMACEUTICAL FORMULATIONS | Molecular Defenses Corporation (US) | 2017-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | GSS, GSR, MGST3 | G6PD 672/4885PMM2 4390/4885MPI 2231/4885 |
| US-20200281967-A1 | Antibiotic Compositions | MRPL21, RPS5, MRPS35 | G6PD 3030/4885PMM2 2715/4885MPI 750/4885 |
| US-20180185410-A1 | Antibiotic Compositions | MRPL21, RPS5, MRPS35 | G6PD 3030/4885PMM2 2715/4885MPI 750/4885 |
| US-11013730-B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | SELENOI, TST, SCLY | G6PD 1736/4885PMM2 4644/4885MPI 1930/4885 |
| US-10653717-B2 | Antibiotic compositions | MRPL21, RPS5, MRPS35 | G6PD 3030/4885PMM2 2715/4885MPI 750/4885 |
| US-11801262-B2 | Antibiotic compositions | MRPL21, RPS5, MRPS35 | G6PD 3030/4885PMM2 2715/4885MPI 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.